| Identification | Back Directory | [Name]
PROTOPANAXTRIOL | [CAS]
34080-08-5 | [Synonyms]
g-PPT
20(S)-APPT
PROTOPANAXTRIOL
S-Protopanaxatriol
PROTOPANAXADIOL(RG)
Protopanaxtriol ,98%
20(S)-Protopanaxtriol
(2S)-Protopanaxatriol
Protopanaxatriol, 20S-
20(S)-Protopanaxtriol(PPT)
(20S)-Protopanaxatriol, >98%
20(S)-Protopanaxatriol 34080-08-5
(20S)-Protopanaxatriol (~91% HPLC)
(3b,6a,12b)-Dammar-24-ene-3,6,12,20-tetrol
(20S)-5α-Dammar-24-ene-3β,6α,12β,20-tetrol
Dammar-24-ene-3,6,12,20-tetrol, (3β,6α,12β)-
Dammar-24-ene-3,6,12,20-tetrol, (3beta,6alpha,12beta)- | [Molecular Formula]
C30H52O4 | [MDL Number]
MFCD01861517 | [MOL File]
34080-08-5.mol | [Molecular Weight]
476.74 |
| Chemical Properties | Back Directory | [Melting point ]
242-244 °C | [Boiling point ]
590.0±50.0 °C(Predicted) | [density ]
1.079 | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
14.73±0.70(Predicted) | [color ]
Off-White | [LogP]
5.890 (est) |
| Hazard Information | Back Directory | [Uses]
(20S)-Protopanaxatriol acts as an inhibitor in the production of corticosteroids in fasciculata cells. Used in the clinical treatment of heart diseases. | [Definition]
ChEBI: Protopanaxatriol is a tetracyclic triterpenoid sapogenin (isolated from ginseng and notoginseng) that is that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions and in which a double bond has been introduced at the 24-25 position. It has a role as a metabolite. It is a tetracyclic triterpenoid, a sapogenin, a 3beta-hydroxy steroid, a 12beta-hydroxy steroid, a 6alpha-hydroxy steroid and a 3beta-hydroxy-4,4-dimethylsteroid. It derives from a hydride of a dammarane. | [target]
Antifection | Glucocorticoid receptor | Oestrogen receptor | LXRα |
|
|